In a recent regulatory development, the Subject Expert Committee (SEC) under the Oncology division of the Central Drugs ...

GSK (GSK) stock in focus as the FDA staff raise safety concerns over Blenrep combo for multiple myeloma ahead of an AdCom meeting. Read more here.